← SynDRA
BOCEPREVIR
SynDRA canonical compound SYN0006377 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | AKR1C3 | CMA1 | CTSA | CTSF | CTSK | CTSL | CTSS | CYP3A5 |
|---|
| Mechanism of action | HCV inhibitor |
|---|
| Indication | hepatitis C |
|---|
| Disease area | infectious disease |
|---|
All known targets
- CMA1
- CTSA
- CTSF
- CTSK
- CTSL
- CTSS
- AKR1C3
- CTSB
- CTSV
- CYP3A5
- ELANE
- HCV NS3/4A
Mechanisms of action (all sources)
- HCV inhibitor
- Modulator
- NS3 INHIBITOR
- NS4A INHIBITOR
Drug classes
- Cytochrome P450 3A4 Inhibitors
- HCV NS3/4A Protease Inhibitors
- Hepatitis C Virus NS3/4A Protease Inhibitor
- Cytochrome P450 3A5 Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- victrelis
- SCH 503034
- Sch 50304
- EBP-520
- SCH-503034
- Victrelis
- EBP 520
- UNII-89BT58KELH
- 89BT58KELH
- CHEBI:68621
- (1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
- 3-{[(1R,2S,5S)-3-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide
- SCH503034
- boceprevirum
- RefChem:56897
- J05AP03
- MFCD22208555
- SCH 50304
- Boceprevir(>90%)
- BOC
- Boceprevir [USAN]
- Boceprevir [USAN:INN]
- C27H45N5O5
- HSDB 8081
- Victrelis(TM)
- Victrelis (TN)
- Boceprevir (Standard)
- Boceprevir & NM107
- BOCEPREVIR [MI]
- BOCEPREVIR [INN]
- Boceprevir (INN/USAN)
- BOCEPREVIR [VANDF]
- BOCEPREVIR [MART.]
- BOCEPREVIR [WHO-DD]
- BOCEPREVIR [EMA EPAR]
- SCHEMBL640836
- EBP520
Look up BOCEPREVIR in the interactive SynDRA portal →